Tidal Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.18M Buy
102,209
+31,316
+44% +$2.58M 0.02% 626
2025
Q4
$6.04M Sell
70,893
-196,391
-73% -$16.1M 0.01% 585
2025
Q3
$20.8M Buy
267,284
+215,885
+420% +$16.9M 0.04% 302
2025
Q2
$4.02M Buy
51,399
+3,495
+7% +$261K 0.02% 499
2025
Q1
$3.47M Buy
47,904
+934
+2% +$66.8K 0.03% 495
2024
Q4
$3.48M Buy
46,970
+7,438
+19% +$521K 0.03% 501
2024
Q3
$2.61M Buy
39,532
+275
+0.7% +$20K 0.03% 527
2024
Q2
$3.63M Buy
39,257
+9,012
+30% +$798K 0.05% 336
2024
Q1
$2.89M Buy
30,245
+10,700
+55% +$899K 0.05% 392
2023
Q4
$1.49M Buy
19,545
+1,291
+7% +$89.8K 0.03% 469
2023
Q3
$1.26M Buy
18,254
+2,909
+19% +$234K 0.04% 471
2023
Q2
$1.45M Sell
15,345
-244
-2% -$21.2K 0.04% 416
2023
Q1
$1.29M Buy
15,589
+1,059
+7% +$83.2K 0.04% 403
2022
Q4
$1.08M Buy
14,530
+1,179
+9% +$90.9K 0.04% 419
2022
Q3
$1.1M Buy
13,351
+698
+6% +$67.2K 0.05% 346
2022
Q2
$1.2M Buy
12,653
+159
+1% +$16.5K 0.04% 338
2022
Q1
$1.47M Buy
12,494
+1,553
+14% +$174K 0.04% 317
2021
Q4
$1.42M Buy
10,941
+1,894
+21% +$221K 0.04% 309
2021
Q3
$1.02M Buy
9,047
+1,397
+18% +$159K 0.04% 328
2021
Q2
$792K Buy
7,650
+2,396
+46% +$226K 0.03% 339
2021
Q1
$439K Buy
5,254
+1,048
+25% +$88.6K 0.02% 326
2020
Q4
$384K Buy
4,206
+747
+22% +$62K 0.03% 268
2020
Q3
$276K Buy
3,459
+417
+14% +$32.5K 0.04% 203
2020
Q2
$210K Buy
+3,042
New +$216K 0.03% 282

Other funds holding EW

Tidal Investments's EW Position: Q1 2026 in Review

Tidal Investments increased its Edwards Lifesciences (EW) stake by 44% in Q1 2026, buying an estimated $2.58M and bringing the position to 102,209 shares worth $8.18M. The position accounts for 0.02% of the portfolio, ranked #626.

Tidal Investments first reported a position in EW in Q2 2020 and has held it in 24 quarters since. The position peaked at $20.8M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Tidal Investments held 102,209 shares of Edwards Lifesciences worth $8.18M as of Q1 2026.
  • Tidal Investments bought 31,316 Edwards Lifesciences shares in Q1 2026, an estimated $2.58M.
  • Edwards Lifesciences made up 0.02% of Tidal Investments's portfolio in Q1 2026, its #626 holding.
  • Tidal Investments first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 24 quarters since.
  • Tidal Investments's Edwards Lifesciences position peaked at $20.8M in Q3 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.